In COPD, new use of long-acting bronchodilators was linked to CV events at ≤ 30 days, but not > 30 days
Abstract
Source Citation
Abstract
Clinical Impact Ratings
Get full access to this article
View all available purchase options and get full access to this article.
References
Information & Authors
Information
Published In
History
Keywords
- Bronchodilators
- Cardiology and cardiovascular diseases
- Cardiovascular diseases
- Chronic obstructive pulmonary disease
- Drugs
- Health care
- Health care facilities
- Health information technology
- Hospital medicine
- International Classification of Diseases
- Odds ratio
- Patients
- Pharmacology
- Prevention, policy, and public health
- Pulmonary diseases
- Pulmonary medicine
- Research and reporting methods
- Respiratory system
- Statistical methods
Copyright
Authors
Metrics & Citations
Metrics
Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
In COPD, new use of long-acting bronchodilators was linked to CV events at ≤ 30 days, but not > 30 days. Ann Intern Med.2018;168:JC47. [Epub 17 April 2018]. doi:10.7326/ACPJC-2018-168-8-047
View More
Get Access
Login Options:
Purchase
You will be redirected to acponline.org to sign-in to Annals to complete your purchase.
Create your Free Account
You will be redirected to acponline.org to create an account that will provide access to Annals.
Submit a Comment
Contributors must reveal any conflict of interest. Comments are moderated. Please see our information for authorsregarding comments on an Annals publication.